Analysis from six randomised controlled trials (331 participants) showed significant improvements with omega-3 supplementation in women with GDM compared to a placebo group: fasting glucose decreased by 0.25 mmol/L, fasting insulin by 17.13 pmol/L, and insulin resistance by 0.51. This evidence concerns the gene INS and gestational diabetes.